L-Carnitine and Sperm: What the Trials Found

It is unlikely to harm you, and it has not been shown to help you have a baby. Pooled across eight randomised trials, carnitine improves measured sperm motility and the proportion of normally shaped sperm. Of the five of those trials that also counted pregnancies, none found a difference.

So the honest split is this. If what you want is a better number on the next semen report, there is some evidence for that, though it is not strong. If what you want is a pregnancy, no trial has shown carnitine delivers one.

After a report that says low motility, a sachet is often the first thing anyone offers, and taking it at least feels like a plan. It is worth knowing what it has and has not been tested to do before it becomes the only plan.

Carnitine occurs naturally in the body and is normally abundant in the fluid of the epididymis, the coiled tube where sperm mature after leaving the testis. Its job in cells generally is to carry fatty acids into the mitochondria, which is where cells burn them for energy. Sperm need energy to swim.

That is the entire reasoning behind the supplement, and it is a reasonable piece of reasoning. It is also not evidence. Plenty of treatments with a clean mechanism fail when they are actually tested, which is why the trials below matter more than the biology.

A note on what this page does not claim. Product pages often add that carnitine protects sperm DNA, improves membrane flexibility or raises sperm counts. None of the nine studies retrieved for this page supports those claims in men, and the pooled analysis of eight randomised trials found no effect on sperm concentration at all.

Two trials sit under almost every carnitine claim. Both were double-blind and placebo-controlled, both ran for six months, and both randomised 60 men.

In the first, men with poor forward motility took L-carnitine with L-acetyl-carnitine, or a placebo. All the sperm measurements rose, but the improvement that reached significance was concentrated in the men who started with the fewest motile sperm of all. In the second, a four-arm trial compared L-carnitine alone, L-acetyl-carnitine alone, the two together and a placebo; motility rose in the arms containing L-acetyl-carnitine, and again the men who responded were those whose motility was worst to begin with.

Neither trial measured whether anyone conceived. That is the single most important thing to know about them, and it is rarely mentioned when they are quoted.

There is also a reason to be careful about the pattern both trials found. When the men who improve are the men who started worst, part of that can be a statistical effect — extreme measurements tend to drift back towards average on retesting whatever you do. Neither trial was designed to separate that from a real response.

Not automatically, and this is where most supplement marketing gets its confidence. A semen analysis measures the sample in the pot. It is a stand-in for fertility, not a measure of it, and a change inside or near the normal range may make no difference to conception at all.

The gap shows up whenever someone looks for it. Pooling 20 randomised trials of carnitine, coenzyme Q10 and selenium, motility rose by about five percentage points on treatment while clinical pregnancy did not separate from placebo, and the reviewers described the semen differences as small and the trial quality as poor. A 2025 review of 50 randomised trials, each running at least 12 weeks, found no effect on pregnancy and no effect on live birth from any dietary supplement, while still recording that carnitine was among the nutrients that improved motility.

The largest placebo-controlled test of a carnitine-containing product points the same way. A seven-ingredient combination including 1,000 mg of L-carnitine daily was given to men with an abnormal semen result; at three months there was no significant difference from placebo in motility, morphology or DNA fragmentation.

Every dose below is the dose a specific trial chose, not a recommendation, and nobody has tested one against another for a pregnancy outcome.

• L-carnitine 2 g a day with L-acetyl-carnitine 1 g a day, for six months, in 60 men (Lenzi 2004).
• L-carnitine 3 g a day, or L-acetyl-carnitine 3 g a day, or the 2 g plus 1 g combination, for six months, in 60 men (Balercia 2005).
• L-carnitine 1,000 mg a day inside a seven-ingredient combination, for three to six months, in 174 men (the Males, Antioxidants and Infertility trial, 2020).

What follows from that is modest. The amounts sold on the Indian market sit in this range because these trials happened to pick these numbers, not because a dose-finding study established them. Neither placebo-controlled trial ran beyond six months, so there is no trial evidence about taking it for longer.

About three months, not three weeks. A cycle of sperm production was measured directly in 11 men who drank deuterium-labelled water: labelled sperm appeared in the ejaculate after a mean of 64 days, give or take about eight, with a full range of 42 to 76 days. Anything started today is acting on sperm that have not entered the pipeline yet.

Two further things make an early retest misleading. The same man produces measurably different samples week to week, so a single change can be ordinary variation. And different laboratories count differently, so a repeat elsewhere is not comparable — use the same lab.

One reference point worth having while you read the report. The dataset behind the World Health Organization's 2021 values puts the lower fifth centile at 16 million per millilitre for concentration, 30% for progressive motility and 4% for normal forms, in a cohort of more than 3,500 men from twelve countries. Its authors state plainly that these do not represent distinct limits between fertile and subfertile men. A result below them is not a diagnosis, and a result above them is not a clearance.

These are the steps that can change the plan, because they can find a cause. A sachet cannot.

• Repeat the semen analysis after about three months, at the same laboratory. One abnormal result is not a diagnosis.
• Ask for a physical examination. A varicocele, a small testicular volume or an absent vas deferens are found by examining, not by supplementing.
• Ask about FSH and testosterone. With testicular volume they separate a production problem from a blockage, and the two are treated completely differently.
• Declare any testosterone, anabolic steroid or gym supplement. Exogenous testosterone suppresses sperm production, and no amount of carnitine offsets it.
• Stop smoking, cut heavy drinking, address weight, and treat a genital tract infection if one is found.

Sometimes the honest answer is that the next step is testing, timing or a simpler treatment rather than anything you swallow. A varicocele, an obstruction or a hormonal problem will not respond to carnitine, and finding one changes everything that follows.

The gaps here are large, and most of the confidence attached to carnitine is borrowed from studies that cannot carry it.

• It does not establish that carnitine increases pregnancy or live birth. Five randomised trials counted pregnancies and none found a difference; the two best-known placebo-controlled trials did not count them at all.
• It does not establish which men benefit. Both placebo-controlled trials found the gain concentrated in men who started worst, which is also what regression towards the mean produces, and neither was designed to distinguish the two.
• It does not establish a dose or a duration. The amounts used were the amounts each trial happened to choose, and no trial has compared one against another for any outcome that matters to a couple.
• It does not support the mechanism claims made for it in marketing. That carnitine protects sperm DNA or improves membrane flexibility in men is not shown by any of the trials retrieved for this page.
• It does not establish long-term safety. Neither placebo-controlled trial ran beyond six months. The pooled adverse-event data across oral antioxidants shows more mild gastrointestinal discomfort than placebo, odds ratio 2.70 (95% CI 1.46 to 4.99) across 16 randomised trials and 1,355 men, and no difference in miscarriage across 6 trials and 664 men, both on low to very low certainty evidence.
• It does not establish that what is in the sachet matches the label. Cochrane states that most antioxidants are uncontrolled by regulation.

• Antioxidants for sperm quality: what the trials found
• Do foods or supplements actually improve sperm quality?
• How to read your semen analysis report
• Supplements sold to couples: what the guidelines say
• Techniques to improve sperm motility
• Male reproductive anatomy: where fertility acts